Aera Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aera Therapeutics's estimated annual revenue is currently $13.6M per year.(i)
  • Aera Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Aera Therapeutics has 88 Employees.(i)
  • Aera Therapeutics grew their employee count by 1% last year.

Aera Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP, Computation and Lab TechnologyReveal Email/Phone
4
Associate Director, Lab InformaticsReveal Email/Phone
5
Associate Director, IT Operations and End User ServicesReveal Email/Phone
6
Director, Head Protein SciencesReveal Email/Phone
7
Senior Director, Therapeutic DiscoveryReveal Email/Phone
8
Associate Director, Delivery TechnologiesReveal Email/Phone
9
Associate Director, FinanceReveal Email/Phone
10
Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Aera Therapeutics?

Aera was founded with a vision to unlock the potential of genetic medicines across a broad range of modalities and therapeutic areas. Our protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous, human proteins that can self-assemble to form capsid-like structures and that can package and transfer nucleic acid cargo. This platform has the potential to address many of the limitations of today’s delivery technologies and to enable various genetic medicine modalities.

keywords:N/A

N/A

Total Funding

88

Number of Employees

$13.6M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.8M8817%N/A
#2
$12.3M889%N/A
#3
$12.8M88-37%$67.4M
#4
$23.8M885%N/A
#5
$13.6M887%$32.3M